IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $260,000 | -32.5% | 7,899 | -43.7% | 0.18% | -34.4% |
| Q2 2020 | $385,000 | -67.3% | 14,032 | -64.3% | 0.28% | -73.2% |
| Q1 2020 | $1,177,000 | +75.1% | 39,322 | +61.9% | 1.04% | +75.3% |
| Q4 2019 | $672,000 | +74.1% | 24,294 | +14.5% | 0.59% | +56.3% |
| Q3 2019 | $386,000 | -31.3% | 21,213 | -7.4% | 0.38% | -25.6% |
| Q2 2019 | $562,000 | +13.8% | 22,903 | -55.9% | 0.51% | -1.5% |
| Q1 2019 | $494,000 | -3.3% | 51,959 | -10.0% | 0.52% | -3.9% |
| Q4 2018 | $511,000 | – | 57,724 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |